BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan C, Hu W, He Y, Zhang Y, Zhang G, Xu Y, Tang J. Cytokine-mediated therapeutic resistance in breast cancer. Cytokine. 2018;108:151-159. [PMID: 29609137 DOI: 10.1016/j.cyto.2018.03.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Choi HS, Kim JH, Kim SL, Lee DS. Disruption of the NF-κB/IL-8 Signaling Axis by Sulconazole Inhibits Human Breast Cancer Stem Cell Formation. Cells 2019;8:E1007. [PMID: 31480284 DOI: 10.3390/cells8091007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
2 Yun HJ, Kim HJ, Kim J, Kim SY, Chang HS, Park CS, Chang HJ, Park KC. Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models. Int J Mol Sci 2021;22:E536. [PMID: 33430361 DOI: 10.3390/ijms22020536] [Reference Citation Analysis]
3 Tong Y, Song Y, Deng S. Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer. Cancer Cell Int 2019;19:50. [PMID: 30867653 DOI: 10.1186/s12935-019-0753-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
4 Chen W, Qin Y, Liu S. Cytokines, breast cancer stem cells (BCSCs) and chemoresistance. Clin Transl Med 2018;7:27. [PMID: 30175384 DOI: 10.1186/s40169-018-0205-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
5 Shaheen S, Fawaz F, Shah S, Büsselberg D. Differential Expression and Pathway Analysis in Drug-Resistant Triple-Negative Breast Cancer Cell Lines Using RNASeq Analysis. Int J Mol Sci 2018;19:E1810. [PMID: 29921827 DOI: 10.3390/ijms19061810] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
6 Smigiel JM, Taylor SE, Bryson BL, Tamagno I, Polak K, Jackson MW. Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant problem. J Cancer Metastasis Treat 2019;5:47. [PMID: 32355893 DOI: 10.20517/2394-4722.2019.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li C, Zhou T, Chen J, Li R, Chen H, Luo S, Chen D, Cai C, Li W. The role of Exosomal miRNAs in cancer. J Transl Med 2022;20:6. [PMID: 34980158 DOI: 10.1186/s12967-021-03215-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Luque-Bolivar A, Pérez-Mora E, Villegas VE, Rondón-Lagos M. Resistance and Overcoming Resistance in Breast Cancer. Breast Cancer (Dove Med Press) 2020;12:211-29. [PMID: 33204149 DOI: 10.2147/BCTT.S270799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tan C, Sun W, Xu Z, Zhu S, Hu W, Wang X, Zhang Y, Zhang G, Wang Z, Xu Y, Tang J. Small extracellular vesicles deliver TGF-β1 and promote adriamycin resistance in breast cancer cells. Mol Oncol 2021;15:1528-42. [PMID: 33508878 DOI: 10.1002/1878-0261.12908] [Reference Citation Analysis]
10 Mohammadinejad R, Biagioni A, Arunkumar G, Shapiro R, Chang KC, Sedeeq M, Taiyab A, Hashemabadi M, Pardakhty A, Mandegary A, Thiery JP, Aref AR, Azimi I. EMT signaling: potential contribution of CRISPR/Cas gene editing. Cell Mol Life Sci 2020;77:2701-22. [PMID: 32008085 DOI: 10.1007/s00018-020-03449-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Shi H, Zhao L, Guo X, Fang R, Zhang H, Dong G, Fu J, Yan F, Zhang J, Ning Z, Ma Q, Li Z, Li C, Dai J, Si C, Xiong H. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int J Mol Sci 2020;21:E6357. [PMID: 32887217 DOI: 10.3390/ijms21176357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mentoor I, Engelbrecht AM, van Jaarsveld PJ, Nell T. Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment. Front Endocrinol (Lausanne) 2018;9:758. [PMID: 30619088 DOI: 10.3389/fendo.2018.00758] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
13 Xu Q, Ma H, Chang H, Feng Z, Zhang C, Yang X. The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway. Cell Death Dis 2020;11:405. [PMID: 32471980 DOI: 10.1038/s41419-020-2627-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wang Y, Lu J, Jiang B, Guo J. The roles of curcumin in regulating the tumor immunosuppressive microenvironment. Oncol Lett 2020;19:3059-70. [PMID: 32256807 DOI: 10.3892/ol.2020.11437] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Glass L, Wente SR. Gle1 mediates stress granule-dependent survival during chemotoxic stress. Adv Biol Regul 2019;71:156-71. [PMID: 30262214 DOI: 10.1016/j.jbior.2018.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
16 Li F, Guo H, Wang Y, Liu B, Zhou H. Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer. Int Immunopharmacol 2020;85:106641. [PMID: 32470882 DOI: 10.1016/j.intimp.2020.106641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
17 Hu W, Xu Z, Zhu S, Sun W, Wang X, Tan C, Zhang Y, Zhang G, Xu Y, Tang J. Small extracellular vesicle-mediated Hsp70 intercellular delivery enhances breast cancer adriamycin resistance. Free Radic Biol Med 2021;164:85-95. [PMID: 33418113 DOI: 10.1016/j.freeradbiomed.2020.12.436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Li Z, Wang J, Chen C, He Q, Xu X, Da Z, Wang B, Wang M, Gao X, Zhang G, Gao Q, Si X, Luo Y, Ma X, Xu B. Intratumoral IL-28B Gene Delivery Elicits Antitumor Effects by Remodeling of the Tumor Microenvironment in H22-Bearing Mice. Journal of Immunology Research 2022;2022:1-13. [DOI: 10.1155/2022/1345971] [Reference Citation Analysis]
19 Gamelas SRD, Moura NMM, Habraken Y, Piette J, Neves MGPMS, Faustino MAF. Tetracationic porphyrin derivatives against human breast cancer. J Photochem Photobiol B 2021;222:112258. [PMID: 34399205 DOI: 10.1016/j.jphotobiol.2021.112258] [Reference Citation Analysis]
20 Jung HH, Kim JY, Cho EY, Oh JM, Lee JE, Kim SW, Nam SJ, Park YH, Ahn JS, Im YH. Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy. Cancers (Basel) 2021;13:5260. [PMID: 34771423 DOI: 10.3390/cancers13215260] [Reference Citation Analysis]
21 Yi Y, Wu M, Zeng H, Hu W, Zhao C, Xiong M, Lv W, Deng P, Zhang Q, Wu Y. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer. Front Oncol 2021;11:738945. [PMID: 34707990 DOI: 10.3389/fonc.2021.738945] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Jung HH, Kim JY, Lim JE, Im YH. Cytokine profiling in serum-derived exosomes isolated by different methods. Sci Rep. 2020;10:14069. [PMID: 32826923 DOI: 10.1038/s41598-020-70584-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
23 Li L, Wang N, Zhu M, Xiong Y, Wang F, Guo G, Wang X, Gu Y. Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma. Cell Death Dis 2021;12:777. [PMID: 34362881 DOI: 10.1038/s41419-021-04060-5] [Reference Citation Analysis]
24 Rompianesi G, Di Martino M, Gordon-Weeks A, Montalti R, Troisi R. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. World J Gastrointest Oncol 2021;13:332-50. [PMID: 34040697 DOI: 10.4251/wjgo.v13.i5.332] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]